Byondis B.V., an independent clinical stage biopharmaceutical company creating innovative targeted medicines for patients with cancer, announces the appointment of Louis Denis, M.D. as Chief Medical Officer. Dr. Denis brings more than 30 years of clinical development leadership and oncology ...

Angels for Change is proud to announce a significant milestone in Project PROTECT, which aims to anticipate and mitigate critical U.S. drug shortages of essential medicines through non-profit partnership.

Fagron Sterile Services US (FSS), a subsidiary of Fagron, recipient of the 2023 Project ...

Avantor, Inc. a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries,announced the opening of its new flagship Bridgewater Innovation Center. The state-of-the-art research and development facility, located in ...

QPS Holdings, LLC announced that their Springfield campus, QPS Missouri, has launched a new Cell Therapy business unit. The unit’s first achievement is the opening of a new Leukopak collection and blood product processing center. This facility is designed to meet the exponentially growing demand ...

Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business, is proud to announce that its most recently FDA-approved magnetic resonance imaging (MRI) agent, VUEWAY® (gadopiclenol) solution for injection, has reached over one ...

Aptar Pharma, a global leader in drug delivery and active material science solutions and services, announced that it has entered into an exclusive collaboration agreement with Cambridge Healthcare Innovations (CHI) to lead the commercialization and promotion of its Quattrii Dry Powder Inhaler (DPI) ...